ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents

Giuseppe Brancatelli, Helmberger, Schima, Ba-Ssalamah, Merkle, Neri, Martì-Bonmatì, Boraschi, Op De Beeck, F. Caseiro Alves, Lee, Martì-Bonmatì, Emanuele Neri, Neri, Neri, Neri, Neri, Skehan, Zech, BaliMatos, Grazioli, Valérie Vilgrain, Manfredi, Bartolozzi

Risultato della ricerca: Articlepeer review

104 Citazioni (Scopus)


Objectives: To develop a consensus and provide updated recommendations on liver MR imaging and the clinical use of liver-specific contrast agents. Methods: The European Society of Gastrointestinal and Abdominal Radiology (ESGAR) formed a multinational European panel of experts, selected on the basis of a literature review and their leadership in the field of liver MR imaging. A modified Delphi process was adopted to draft a list of statements. Descriptive and Cronbach’s statistics were used to rate levels of agreement and internal reliability of the consensus. Results: Three Delphi rounds were conducted and 76 statements composed on MR technique (n = 17), clinical application of liver-specific contrast agents in benign, focal liver lesions (n = 7), malignant liver lesions in non-cirrhotic (n = 9) and in cirrhotic patients (n = 18), diffuse and vascular liver diseases (n = 12), and bile ducts (n = 13). The overall mean score of agreement was 4.84 (SD ±0.17). Full consensus was reached in 22 % of all statements in all working groups, with no full consensus reached on diffuse and vascular diseases. Conclusions: The consensus provided updated recommendations on the methodology, and clinical indications, of MRI with liver specific contrast agents in the study of liver diseases. Key points: • Liver-specific contrast agents are recommended in MRI of the liver. • The hepatobiliary phase improves the detection and characterization of hepatocellular lesions. • Liver-specific contrast agents can improve the detection of HCC.
Lingua originaleEnglish
pagine (da-a)921-931
Numero di pagine11
RivistaEuropean Radiology
Stato di pubblicazionePublished - 2016

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2741???


Entra nei temi di ricerca di 'ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents'. Insieme formano una fingerprint unica.

Cita questo